Stifel Nicolaus Issues Pessimistic Forecast for Cooper Companies (NASDAQ:COO) Stock Price

Key Points

• Stifel Nicolaus has lowered its price target for Cooper Companies' stock from $90.00 to $85.00, maintaining a "buy" rating but indicating a potential upside of 34% from the last closing price.
• Several brokerages have also revised their target prices, with estimates ranging from $76.00 to $100.00, reflecting a cautious outlook on the company's stock performance.
• Despite current pressures, Cooper Companies reported $1.10 earnings per share for its latest quarter, exceeding the consensus estimate, and has provided guidance for Q4 2025 EPS in the range of 1.100-1.140.

Cooper Companies (NASDAQ:COO - Get Free Report) had its price objective dropped by investment analysts at Stifel Nicolaus from $90.00 to $85.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the medical device company's stock. Stifel Nicolaus' price objective indicates a potential upside of 34.00% from the company's previous close.

Several other brokerages have also recently issued reports on COO. Loop Capital set a $100.00 price objective on Cooper Companies in a research note on Tuesday, June 17th. Wells Fargo & Company dropped their target price on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a report on Friday, May 30th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Piper Sandler reissued an "overweight" rating and issued a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $94.00 target price on shares of Cooper Companies in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $94.91.

Cooper Companies Stock Down 14.4%

Shares of NASDAQ COO opened at $63.44 on Thursday. The stock has a market cap of $12.69 billion, a P/E ratio of 30.49, a PEG ratio of 1.80 and a beta of 1.00. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. Cooper Companies has a 12-month low of $62.70 and a 12-month high of $112.38. The business's fifty day simple moving average is $72.44 and its 200-day simple moving average is $77.88.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The company's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period last year, the firm earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities analysts predict that Cooper Companies will post 3.98 EPS for the current fiscal year.

Hedge Funds Weigh In On Cooper Companies

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock worth $2,194,000 after buying an additional 3,440 shares during the last quarter. DAVENPORT & Co LLC lifted its position in Cooper Companies by 13.4% in the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock valued at $366,000 after purchasing an additional 513 shares during the period. Cerity Partners LLC lifted its position in Cooper Companies by 6.6% in the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock valued at $1,443,000 after purchasing an additional 1,054 shares during the period. State of Alaska Department of Revenue lifted its position in Cooper Companies by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock valued at $1,972,000 after purchasing an additional 680 shares during the period. Finally, Cetera Investment Advisers lifted its position in Cooper Companies by 1.3% in the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock valued at $2,211,000 after purchasing an additional 312 shares during the period. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.